Published in J Immunol on October 01, 1999
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun (2000) 3.27
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev (2002) 1.97
Immune response to infection with Mycobacterium ulcerans. Infect Immun (2001) 1.82
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol (2009) 1.77
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother (2010) 1.72
Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun (2002) 1.65
Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect Immun (2005) 1.59
Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans. J Bacteriol (2005) 1.55
Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun (2002) 1.54
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med (2007) 1.48
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun (2007) 1.40
Mycobacterium ulcerans cytotoxicity in an adipose cell model. Infect Immun (2001) 1.35
Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease. Infect Immun (2004) 1.34
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria. Nat Prod Rep (2008) 1.32
Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis (2008) 1.27
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? Future Microbiol (2011) 1.20
The local immune response in ulcerative lesions of Buruli disease. Clin Exp Immunol (2006) 1.13
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana. Clin Diagn Lab Immunol (2005) 1.11
Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue. PLoS Negl Trop Dis (2010) 1.11
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin. PLoS Negl Trop Dis (2013) 1.10
Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer). Clin Diagn Lab Immunol (2002) 1.08
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER. PLoS Pathog (2014) 1.05
Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation. J Clin Invest (2013) 1.04
Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis. Infect Immun (2004) 0.99
Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring. PLoS Negl Trop Dis (2011) 0.99
Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease. BMC Infect Dis (2014) 0.98
Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer. PLoS Negl Trop Dis (2009) 0.95
Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect Immun (2009) 0.95
Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response. Infect Immun (2006) 0.89
Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic. Clin Diagn Lab Immunol (2004) 0.87
Chemistry of mycolactones, the causative toxins of Buruli ulcer. Proc Natl Acad Sci U S A (2011) 0.87
Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen. PLoS Negl Trop Dis (2014) 0.86
Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity. PLoS One (2010) 0.85
Identification of a novel gene product that promotes survival of Mycobacterium smegmatis in macrophages. PLoS One (2012) 0.83
Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans. PLoS Negl Trop Dis (2013) 0.82
Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas. Clin Exp Immunol (2009) 0.81
Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone. J Cell Sci (2016) 0.81
Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease. PLoS Negl Trop Dis (2014) 0.80
Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease. Cell Microbiol (2016) 0.79
Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice. PLoS Negl Trop Dis (2016) 0.78
Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions. PLoS Pathog (2015) 0.78
Scalable and efficient synthesis of the mycolactone core. Tetrahedron (2010) 0.77
Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage. PLoS One (2012) 0.77
Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis. J Cell Sci (2017) 0.75
Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci (2001) 9.49
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science (1999) 6.37
Postinfectious fatigue: prospective cohort study in primary care. Lancet (1995) 5.21
Population based study of fatigue and psychological distress. BMJ (1994) 5.15
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92
Comparison of the ability of enteroinvasive Escherichia coli, Salmonella typhimurium, Yersinia pseudotuberculosis, and Yersinia enterocolitica to enter and replicate within HEp-2 cells. Infect Immun (1987) 3.81
Lyme carditis: an important cause of reversible heart block. Ann Intern Med (1989) 3.81
Acid resistance in enteric bacteria. Infect Immun (1993) 3.53
Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb Cortex (2003) 3.50
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun (2000) 3.27
Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94
Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol (1991) 2.88
Human factors and cardiac surgery: a multicenter study. J Thorac Cardiovasc Surg (2000) 2.77
Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis. J Clin Microbiol (1998) 2.58
A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. J Med Microbiol (1994) 2.46
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. II. Ophthalmia neonatorum due to TRIC agent. Trans Ophthalmol Soc U K (1966) 2.46
Why is the infectious stage of syphilis prolonged? Br J Vener Dis (1974) 2.36
First year donation patterns predict long-term commitment for first-time donors. Vox Sang (2005) 2.18
Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry (1999) 2.14
Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J (2001) 2.07
Identification of sigma S-dependent genes associated with the stationary-phase acid-resistance phenotype of Shigella flexneri. Mol Microbiol (1996) 2.02
Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol (1999) 1.97
New antibody in early syphilis. Lancet (1970) 1.97
Should exercise blood pressure be measured in clinical practice? J Hypertens (1998) 1.97
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
Human ehrlichiosis in the UK. Lancet (1995) 1.96
Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol (1998) 1.96
Relation of TRIC agent to "non-specific genital infection". Br J Vener Dis (1966) 1.94
Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. Infect Immun (1998) 1.93
Genetic and biochemical approach for characterization of resistance to Bacillus thuringiensis toxin Cry1Ac in a field population of the diamondback moth, Plutella xylostella. Appl Environ Microbiol (2000) 1.92
Management of infected aortoiliac aneurysms. Arch Surg (1991) 1.92
p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem (2000) 1.88
Observations on syphilis in Addis Ababa. 2. Prevalence and natural history. Br J Vener Dis (1977) 1.87
Induction of the angiogenic phenotype by Hox D3. J Cell Biol (1997) 1.84
The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol (2002) 1.83
A Change in a Single Midgut Receptor in the Diamondback Moth (Plutella xylostella) Is Only in Part Responsible for Field Resistance to Bacillus thuringiensis subsp. kurstaki and B. thuringiensis subsp. aizawai. Appl Environ Microbiol (1997) 1.80
Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source. Epidemiol Infect (1989) 1.78
High-performance liquid chromatography of naturally occurring 8-, 7-, 6-, 5- and 4-carboxylic porphyrin isomers. J Chromatogr (1983) 1.77
Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect Immun (1995) 1.67
DDD pacing mode survival in patients with a dual-chamber pacemaker. J Am Coll Cardiol (1992) 1.65
The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire. J Neurol Neurosurg Psychiatry (1988) 1.64
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother (1993) 1.62
Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) (2008) 1.59
Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect Immun (1997) 1.58
Oxygen therapy after abdominal surgery. Br J Anaesth (1977) 1.55
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS (2000) 1.54
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis (2001) 1.53
The early management of severe tibial pilon fractures using a temporary ring fixator. Surgeon (2003) 1.52
A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients. Eur Heart J (2002) 1.52
Emerging pattern of Lyme disease in the United Kingdom and Irish Republic. Lancet (1987) 1.49
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Removal of infected transvenous leads requiring cardiopulmonary bypass or inflow occlusion. J Thorac Cardiovasc Surg (1992) 1.48
Purification and subunit structure of legumin of Vicia faba L. (broad bean). Biochem J (1974) 1.47
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Sulphamethoxazole combined with 2-4-diamino-pyrimidines in the treatment of gonorrhoea. Br J Vener Dis (1970) 1.46
Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology (1994) 1.45
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS (2001) 1.45
Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J Parasitol (1989) 1.44
Characterization of the acid resistance phenotype and rpoS alleles of shiga-like toxin-producing Escherichia coli. Infect Immun (1996) 1.44
Acid-sensitive enteric pathogens are protected from killing under extremely acidic conditions of pH 2.5 when they are inoculated onto certain solid food sources. Appl Environ Microbiol (1998) 1.40
Implantable cardioverter defibrillator: what a hospital practitioner needs to know. Eur J Intern Med (2009) 1.39
The ankle clonus test for assessment of the integrity of the spinal cord during operations for scoliosis. J Bone Joint Surg Am (1997) 1.39
Why the assay of serum cystine by protein precipitation and chromatography should be abandoned. Ann Clin Biochem (1988) 1.39
The bunged bung--one-way valve malfunction during elective surgery. Anaesth Intensive Care (2008) 1.39
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion (1994) 1.38
Early diagnosis of acute myocardial infarction with use of a rapid immunochemical assay of creatine kinase MB isoenzyme. Clin Chem (1993) 1.38
The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein. Mol Microbiol (1998) 1.37
Untreated milk as a source of verotoxigenic E coli O157. Vet Rec (1993) 1.37
An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. J Natl Cancer Inst (1985) 1.37
Neutralizing activities of antisera to poxvirus soluble antigens. J Gen Virol (1974) 1.36
Mycobacterium ulcerans cytotoxicity in an adipose cell model. Infect Immun (2001) 1.35
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. 3. Genital infection and disease of the eye. Trans Ophthalmol Soc U K (1966) 1.35
Preparation of antibody-toxin conjugates. Methods Enzymol (1985) 1.34
Topography of projections from the medial prefrontal cortex to the amygdala in the rat. Brain Res Bull (1986) 1.33
IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol (1998) 1.33
Serology of Lyme disease. Lancet (1986) 1.32
Separation of porphyrin isomers by high-performance liquid chromatography. Biochem J (1983) 1.29
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis (1997) 1.28
Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol (2001) 1.27
Complete structure of the mycolactones. J Am Chem Soc (2001) 1.27
The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun (2001) 1.26
Analysis of 153 deaths after upper gastrointestinal endoscopy: room for improvement? Surg Endosc (2003) 1.26
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant. Proc Natl Acad Sci U S A (2006) 1.26
Changing concepts of deep venous thrombosis of the upper extremity--report of a series and review of the literature. Surgery (1988) 1.26
Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol (2001) 1.25
Stereochemistry of the core structure of the mycolactones. J Am Chem Soc (2001) 1.25
mRna expression analysis of tissue sections and single cells. J Neurosci (2001) 1.25
T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem (1997) 1.24
Engineering desiccation tolerance in Escherichia coli. Appl Environ Microbiol (2000) 1.24
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. J Immunol (2001) 1.24
First-time blood donors: demographic trends. Transfusion (2001) 1.23
Active Fe-containing superoxide dismutase and abundant sodF mRNA in Nostoc commune (Cyanobacteria) after years of desiccation. J Bacteriol (2000) 1.23
Classification and analysis of incidents in complex medical environments. Top Health Inf Manage (2000) 1.22
The adjusted serum calcium concept--a reappraisal. Ann Clin Biochem (1986) 1.18
Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J Biol Chem (2001) 1.17